Theratechnologies inc.
TSX : TH

Theratechnologies inc.

November 17, 2006 08:00 ET

Theratechnologies' CEO, One of the Keynote Speakers at BioNorth Biotechnology and Life Sciences Conference in Ottawa

MONTREAL, QUEBEC--(CCNMatthews - Nov. 17, 2006) - Theratechnologies (TSX:TH) announced today that Yves Rosconi, President and Chief Executive Officer of the Company, will be one of the keynote speakers at the BioNorth Biotechnology and Life Sciences Conference which will be held on November 20 and 21 at the Ottawa Congress Centre. Mr. Rosconi's address will be entitled "Competing globally - Can a Canadian life sciences company bring its own products to market?" Mr. Rosconi will be speaking at a luncheon scheduled to take place at noon on Monday, November 20th.

About Theratechnologies

Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers or acquires novel therapeutic products for development and commercialization. These products target unmet medical needs in commercially attractive specialty markets. The most advanced program is in Phase 3 clinical development in HIV-associated lipodystrophy. The Company also has other promising projects at various stages of development.

Contact Information